B
Bharat B. Mittal
Researcher at Northwestern University
Publications - 149
Citations - 9393
Bharat B. Mittal is an academic researcher from Northwestern University. The author has contributed to research in topics: Radiation therapy & Head and neck cancer. The author has an hindex of 42, co-authored 141 publications receiving 7854 citations. Previous affiliations of Bharat B. Mittal include Ohio State University & University of Chicago.
Papers
More filters
Journal ArticleDOI
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
David G. Pfister,Sharon A. Spencer,David J. Adelstein,Douglas Adkins,Yoshimi Anzai,David M. Brizel,Justine Yang Bruce,Paul M. Busse,Jimmy J. Caudell,Anthony J. Cmelak,A. Dimitrios Colevas,David W. Eisele,Moon Fenton,Robert L. Foote,Thomas J. Galloway,Maura L. Gillison,Robert I. Haddad,Wesley L. Hicks,Ying J. Hitchcock,Antonio Jimeno,Debra S. Leizman,Ellie Maghami,Loren K. Mell,Bharat B. Mittal,Harlan A. Pinto,John A. Ridge,James W. Rocco,Cristina P. Rodriguez,Jatin P. Shah,Randal S. Weber,Gregory S. Weinstein,Matthew E. Witek,Frank Worden,Sue S. Yom,Weining Zhen,Jennifer L. Burns,Susan Darlow +36 more
TL;DR: The NCCN Guidelines for Head and Neck Cancers as mentioned in this paper describe supportive care recommendations for patients with H&N cancers and the rationale supporting a new section on imaging recommendations for head and neck cancers.
Journal ArticleDOI
Head and Neck Cancers
David G. Pfister,K. Kian Ang,David M. Brizel,Barbara Burtness,Anthony J. Cmelak,A. Dimitrios Colevas,Frank Dunphy,David W. Eisele,Jill Gilbert,Maura L. Gillison,Robert I. Haddad,Bruce H. Haughey,Wesley L. Hicks,Ying J. Hitchcock,Merrill S. Kies,William M. Lydiatt,Ellie Maghami,Renato G. Martins,Thomas V. McCaffrey,Bharat B. Mittal,Harlan A. Pinto,John A. Ridge,Sandeep Samant,Giuseppe Sanguineti,David E. Schuller,Jatin P. Shah,Sharon A. Spencer,Andy Trotti,Randal S. Weber,Gregory T. Wolf,Frank Worden +30 more
TL;DR: The role of eIF4E and some other translation factors as they relate to the biology and treatment of HNSCC are discussed.
Journal ArticleDOI
Phase III Randomized Trial of Induction Chemotherapy in Patients With N2 or N3 Locally Advanced Head and Neck Cancer
Ezra E.W. Cohen,Theodore Karrison,Masha Kocherginsky,Jeffrey Mueller,Robyn Egan,Chao H. Huang,Bruce Brockstein,Mark Agulnik,Bharat B. Mittal,Furhan Yunus,Sandeep Samant,Luis E. Raez,Ranee Mehra,Priya Kumar,Frank G. Ondrey,Patrice Marchand,Bettina Braegas,Tanguy Y. Seiwert,Victoria M. Villaflor,Daniel J. Haraf,Everett E. Vokes +20 more
TL;DR: The study was underpowered because it did not meet the planned accrual target, and OS was higher than predicted in both arms, but IC cannot be recommended routinely in patients with N2 or N3 locally advanced SCCHN.
Journal ArticleDOI
Predictors of Competing Mortality in Advanced Head and Neck Cancer
Loren K. Mell,James J. Dignam,Joseph K. Salama,Ezra E.W. Cohen,Blase N. Polite,Virag Dandekar,Amit D. Bhate,Mary Ellyn Witt,Daniel J. Haraf,Bharat B. Mittal,Everett E. Vokes,Ralph R. Weichselbaum +11 more
TL;DR: Competing mortality in advanced head and neck cancer is associated with several demographic and health status characteristics and analyses of risk factors for competing mortality may be useful in outcomes reporting and designing clinical trials.
Journal ArticleDOI
NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018
A. Dimitrios Colevas,Sue S. Yom,David G. Pfister,Sharon A. Spencer,David J. Adelstein,Douglas Adkins,David M. Brizel,Barbara Burtness,Paul M. Busse,Jimmy J. Caudell,Anthony J. Cmelak,David W. Eisele,Moon Fenton,Robert L. Foote,Jill Gilbert,Maura L. Gillison,Robert I. Haddad,Wesley L. Hicks,Ying J. Hitchcock,Antonio Jimeno,Debra S. Leizman,Ellie Maghami,Loren K. Mell,Bharat B. Mittal,Harlan A. Pinto,John A. Ridge,James W. Rocco,Cristina P. Rodriguez,Jatin P. Shah,Randal S. Weber,Matthew E. Witek,Frank Worden,Weining Zhen,Jennifer L. Burns,Susan Darlow +34 more
TL;DR: These NCCN Guidelines Insights summarize the panel's discussion and most recent recommendations regarding evaluation and treatment of nasopharyngeal carcinoma.